- HCW Biologics (NASDAQ:HCWB): Q2 Net loss was $2.8M as compared to $2.8M for the second quarter of 2020.
- On June 30, 2021, the Company’s cash balance was $5.1M.
- Together with net proceeds of $49.0M from the IPO, the Company estimates that it has sufficient cash to fund operations and capital expenditures for at least the next 24 months.
HCW Biologics reports Q2 results
Recommended For You
More Trending News
About HCWB Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
HCWB | - | - |
HCW Biologics Inc. |